I-FACTOR PEPTIDE ENHANCED BONE GRAFT
Cerapedics, LLC · Decision date Nov 3, 2015
What did the FDA approve?
FDA records P140019 as an original PMA application. The recorded decision is approval, dated Nov 3, 2015.
FDA approval order statement
APPROVAL FOR THE I-FACTOR PEPTIDE ENHANCED BONE GRAFT. THIS COMBINATION PRODUCT IS INDICATED FOR USE IN SKELETALLY MATURE PATIENTS FOR RECONSTRUCTION OF A DEGENERATED CERVICAL DISC AT ONE LEVEL FROM C3-C4 TO C6-C7 FOLLOWING SINGLE-LEVEL DISCECTOMY FOR INTRACTABLE RADICULOPATHY (ARM PAIN AND/OR A NEUROLOGICAL DEFICIT), WITH OR WITHOUT NECK PAIN, OR MYELOPATHY DUE TO A SINGLE-LEVEL ABNORMALITY LOCALIZED TO THE DISC SPACE, AND CORRESPONDING TO AT LEAST ONE OF THE FOLLOWING CONDITIONS CONFIRMED BY RADIOGRAPHIC IMAGING (CT, MRI, X-RAYS): HERNIATED NUCLEUS PULPOSUS, SPONDYLOSIS (DEFINED BY THE PRESENCE OF OSTEOPHYTES), AND/OR VISIBLE LOSS OF DISC HEIGHT AS COMPARED TO ADJACENT LEVELS, AFTER FAILURE OF AT LEAST 6 WEEKS OF CONSERVATIVE TREATMENT. I-FACTOR PEPTIDE ENHANCED BONE GRAFT P-15 PUTTY MUST BE USED INSIDE AN ALLOGRAFT BONE RING AND WITH SUPPLEMENTAL ANTERIOR PLATE FIXATION.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Orthopedic
- Decision date
- Nov 3, 2015
Regulatory record facts
- Identifier
- P140019
- Regulatory pathway
- Premarket approval application
- Applicant
- Cerapedics, LLC
- Product code
- NOX
- Decision code
- APPR
- Decision date
- Nov 3, 2015
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Filler, bone void, synthetic peptide.
- Applicant
- Cerapedics, LLC
- Product code
- NOX
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P140019 received
Application receipt date recorded by FDA.
P140019 · FDA decision
APPR
P140019/S014 · Related supplement
i-F ACTOR Peptide Enhanced Graft Substitute
Timeline entries are records held by MedtechLedger for P140019. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140019
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
i-F ACTOR Peptide Enhanced Graft SubstituteP140019/S014 | Cerapedics, LLC | PMA supplement | Sep 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NOX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PearlMatrixTM Peptide Enhanced Bone GraftP240001/S003 | Cerapedics, Inc. | PMA supplement | Sep 16, 2026 | FDA |
PearlMatrix Bone GraftP240001 | Cerapedics, Inc. | PMA approval | Jun 18, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cerapedics, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 11025 Dover St., Suite 1600, Westminster, CO, 80021
Sources and methodology
- Original FDA record: P140019
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
